Charles Schwab’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.01M Buy
185,797
+8,632
+5% +$46.9K ﹤0.01% 2896
2025
Q1
$615K Buy
177,165
+3,966
+2% +$13.8K ﹤0.01% 3010
2024
Q4
$1.78M Buy
173,199
+30,611
+21% +$315K ﹤0.01% 2713
2024
Q3
$1.93M Buy
142,588
+5,126
+4% +$69.5K ﹤0.01% 2716
2024
Q2
$1.79M Buy
137,462
+6,857
+5% +$89.1K ﹤0.01% 2738
2024
Q1
$1.23M Buy
130,605
+2,350
+2% +$22.2K ﹤0.01% 2727
2023
Q4
$1.41M Buy
128,255
+1,400
+1% +$15.4K ﹤0.01% 2717
2023
Q3
$811K Buy
126,855
+23,585
+23% +$151K ﹤0.01% 2866
2023
Q2
$497K Buy
103,270
+16,492
+19% +$79.3K ﹤0.01% 3055
2023
Q1
$358K Sell
86,778
-777
-0.9% -$3.2K ﹤0.01% 3049
2022
Q4
$376K Buy
+87,555
New +$376K ﹤0.01% 3063